- Home
- GLMD vs LGHL Comparison
GLMD vs LGHL Comparison
Compare GLMD & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- LGHL
- Stock Information
- Founded
- GLMD 2000
- LGHL 2015
- Country
- GLMD Israel
- LGHL Singapore
- Employees
- GLMD N/A
- LGHL N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- GLMD Health Care
- LGHL Finance
- Exchange
- GLMD Nasdaq
- LGHL Nasdaq
- Market Cap
- GLMD 4.6M
- LGHL 4.3M
- IPO Year
- GLMD 2014
- LGHL N/A
- Fundamental
- Price
- GLMD $2.94
- LGHL $0.14
- Analyst Decision
- GLMD
- LGHL
- Analyst Count
- GLMD 0
- LGHL 0
- Target Price
- GLMD N/A
- LGHL N/A
- AVG Volume (30 Days)
- GLMD 31.0K
- LGHL 4.6M
- Earning Date
- GLMD 11-14-2024
- LGHL 01-28-2025
- Dividend Yield
- GLMD N/A
- LGHL N/A
- EPS Growth
- GLMD N/A
- LGHL N/A
- EPS
- GLMD N/A
- LGHL N/A
- Revenue
- GLMD N/A
- LGHL $13,659,110.00
- Revenue This Year
- GLMD N/A
- LGHL N/A
- Revenue Next Year
- GLMD N/A
- LGHL N/A
- P/E Ratio
- GLMD N/A
- LGHL N/A
- Revenue Growth
- GLMD N/A
- LGHL 11.35
- 52 Week Low
- GLMD $2.56
- LGHL $0.13
- 52 Week High
- GLMD $23.80
- LGHL $1.55
- Technical
- Relative Strength Index (RSI)
- GLMD 47.92
- LGHL 37.92
- Support Level
- GLMD $2.84
- LGHL $0.14
- Resistance Level
- GLMD $3.02
- LGHL $0.17
- Average True Range (ATR)
- GLMD 0.23
- LGHL 0.03
- MACD
- GLMD -0.01
- LGHL -0.00
- Stochastic Oscillator
- GLMD 18.29
- LGHL 2.64
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.